The present invention relates to triazine compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating autoimmune, inflammatory, and neurodegenerative diseases by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

The present invention relates to a triazine precondensate according to the general formula (I) where R.sub.1 means Q.sup.1 or a moiety of the formula R.sub.3NR.sub.4 connected with the nitrogen atom to the triazine ring of the structure of formula (I), where R.sub.9 means Q.sup.1 or a moiety of the formula R.sub.7NR.sub.8 connected with the nitrogen atom to the triazine ring of the structure of formula (I), where R.sub.2, R.sub.3, R.sub.4 and R.sub.6 mean independently from each other H, Q.sup.1 or (i), R.sub.7 and R.sub.8 mean independently from each other H, Q.sup.1, (ii) or (iii) or (i), R.sub.10 and R.sub.11 mean independently from each other R.sub.7 or R.sub.8; R.sub.5 means linear or branched C.sub.2-C.sub.20-alkyl that can be interrupted by one or more oxygen atoms, sulphur atoms, substituted or non-substituted nitrogen atoms.

The present invention relates to a triazine precondensate according to the general formula (I) where R.sub.1 means Q.sup.1 or a moiety of the formula R.sub.3NR.sub.4 connected with the nitrogen atom to the triazine ring of the structure of formula (I), where R.sub.9 means Q.sup.1 or a moiety of the formula R.sub.7NR.sub.8 connected with the nitrogen atom to the triazine ring of the structure of formula (I), where R.sub.2, R.sub.3, R.sub.4 and R.sub.6 mean independently from each other H, Q.sup.1 or (i), R.sub.7 and R.sub.8 mean independently from each other H, Q.sup.1, (ii) or (iii) or (i), R.sub.10 and R.sub.11 mean independently from each other R.sub.7 or R.sub.8; R.sub.5 means linear or branched C.sub.2-C.sub.20-alkyl that can be interrupted by one or more oxygen atoms, sulphur atoms, substituted or non-substituted nitrogen atoms.

A polyester resin composition containing 100 parts by mass of a polyester resin and 0.01 to 10 parts by mass of a 2-amino-1,3,5-triazine derivative of Formula [1]: ##STR00001##
a polyester resin molded body obtained by the composition, and a crystal nucleating agent including the triazine derivative. A polyester resin composition containing a crystal nucleating agent that makes it possible to produce, with high productivity, a polyester resin molded product that promotes polyester resin crystallization and maintains high transparency after crystallization and is applicable for a wide variety of uses can be provided.

A polyester resin composition containing 100 parts by mass of a polyester resin and 0.01 to 10 parts by mass of a 2-amino-1,3,5-triazine derivative of Formula [1]: ##STR00001##
a polyester resin molded body obtained by the composition, and a crystal nucleating agent including the triazine derivative. A polyester resin composition containing a crystal nucleating agent that makes it possible to produce, with high productivity, a polyester resin molded product that promotes polyester resin crystallization and maintains high transparency after crystallization and is applicable for a wide variety of uses can be provided.

The present invention relates to novel mono- or polynuclear melamine compounds and their use as dispersants for pigments and fillers in coating compositions, in particular in solvent-borne coating compositions. The mono- or polynuclear melamine compounds of the invention have at least one 2,4,6-triamino-1,3,5-triazine ring, wherein at least one amino groups of at least one of the 2,4,6-triamino-1,3,5-triazine rings of the mono- or polynuclear melamine compounds is of the formula A:NR.sup.1R.sup.2 (A) where R.sup.1 is H, CH(R.sup.3)OR.sup.4 or R.sup.2, R.sup.2 is CH(R.sup.3)0(A-0).sub.x-R.sup.5, where R.sup.3 is H, C.sub.1-C.sub.10-alkyl or aryl; R.sup.4 is H, C.sub.1-C.sub.4-alkyl or C.sub.1-C.sub.4-alkoxy-C.sub.1-C.sub.4-alkyl; R.sup.5 is a hydrocarbon radical having from 1 to 40 carbon atoms; x is an integer from 2 to 500, having on average a value in the range from 2.5 to 400; A is an C.sub.2-C.sub.4-alkan-1,2-diyl radical.

Novel fluorescent whitening agents, compositions or mixtures thereof with known fluorescent whitening agents, their preparation, and their use. The novel fluorescent whitening agents (FWAs) contain three structural subunits derived from 4,4-diamino-2,2-stilbenedisulfonic acid. The novel compounds and their mixtures with known FWAs show very good effectiveness as fluorescent whitening agents for cellulosic materials, in particular for paper.

Novel fluorescent whitening agents, compositions or mixtures thereof with known fluorescent whitening agents, their preparation, and their use. The novel fluorescent whitening agents (FWAs) contain three structural subunits derived from 4,4-diamino-2,2-stilbenedisulfonic acid. The novel compounds and their mixtures with known FWAs show very good effectiveness as fluorescent whitening agents for cellulosic materials, in particular for paper.

Surface-modified nanoparticles are produced by associating ligand interactive agents with the surface of a nanoparticle. The ligand interactive agents are bound to surface modifying ligands that are tailored to impart particular solubility and/or compatibility properties. The ligand interactive agents are crosslinked via a linking/crosslinking agent. The linking/crosslinking agent may provide a binding site for binding the surface modifying ligands to the ligand interactive agents.

Surface-modified nanoparticles are produced by associating ligand interactive agents with the surface of a nanoparticle. The ligand interactive agents are bound to surface modifying ligands that are tailored to impart particular solubility and/or compatibility properties. The ligand interactive agents are crosslinked via a linking/crosslinking agent. The linking/crosslinking agent may provide a binding site for binding the surface modifying ligands to the ligand interactive agents.